Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 2.53p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.25
  • 52 Week Low: 2.48
  • Currency: UK Pounds
  • Shares Issued: 356.04m
  • Volume: 0
  • Market Cap: £8.99m
  • RiskGrade: 288

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
71.46% below the market average71.46% below the market average71.46% below the market average71.46% below the market average71.46% below the market average
38.18% below the sector average38.18% below the sector average38.18% below the sector average38.18% below the sector average38.18% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
82.4% below the market average82.4% below the market average82.4% below the market average82.4% below the market average82.4% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average
Price Chg 3m
62.60% above the market average62.60% above the market average62.60% above the market average62.60% above the market average62.60% above the market average
56.67% above the sector average56.67% above the sector average56.67% above the sector average56.67% above the sector average56.67% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
17.61% below the market average17.61% below the market average17.61% below the market average17.61% below the market average17.61% below the market average
37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
50.23% below the market average50.23% below the market average50.23% below the market average50.23% below the market average50.23% below the market average
44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average44.83% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
75.89% below the market average75.89% below the market average75.89% below the market average75.89% below the market average75.89% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Cash
51.25% below the market average51.25% below the market average51.25% below the market average51.25% below the market average51.25% below the market average
64.91% below the sector average64.91% below the sector average64.91% below the sector average64.91% below the sector average64.91% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 2.53p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.25
52 Week Low 2.48
Volume 0
Shares Issued 356.04m
Market Cap £8.99m
RiskGrade 288

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.14% above the market average23.14% above the market average23.14% above the market average23.14% above the market average23.14% above the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average
Value
23.14% above the market average23.14% above the market average23.14% above the market average23.14% above the market average23.14% above the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for --2019

Time Volume / Share Price
0 @ 0.000p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page